4.6 Article

Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Effect of nucleoside analog use in patients with hepatitis B virus-related hepatocellular carcinoma

Hiroki Nishikawa et al.

HEPATOLOGY RESEARCH (2014)

Article Gastroenterology & Hepatology

Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment

Grace Lai-Hung Wong et al.

GASTROENTEROLOGY (2013)

Article Medicine, General & Internal

Association Between Nucleoside Analogues and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Following Liver Resection

Chun-Ying Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Gastroenterology & Hepatology

Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma

Liang Huang et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma

Yorihisa Urata et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)

Article Gastroenterology & Hepatology

Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B

Eugene R. Schiff et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

High Hepatitis B Viral Load Predicts Recurrence of Small Hepatocellular Carcinoma after Curative Resection

Li-Shuai Qu et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2010)

Article Gastroenterology & Hepatology

Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach

Ying-Chun Shen et al.

JOURNAL OF HEPATOLOGY (2010)

Article Gastroenterology & Hepatology

Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma

Jaw-Ching Wu et al.

JOURNAL OF HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection

Ivan F. N. Hung et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

Teiji Kuzuya et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)

Review Gastroenterology & Hepatology

Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis

Hashem B. El-Serag et al.

GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

Stephanos J. Hadziyannis et al.

GASTROENTEROLOGY (2006)

Article Medicine, General & Internal

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

CJ Chen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Oncology

Global cancer statistics, 2002

DM Parkin et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2005)

Article Gastroenterology & Hepatology

Hepatocellular carcinoma in cirrhosis: Incidence and risk factors

G Fattovich et al.

GASTROENTEROLOGY (2004)

Article Medicine, General & Internal

Lamivudine for patients with chronic hepatitis B and advanced liver disease

YF Liaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Gastroenterology & Hepatology

Peginterferon α-2a (40 kDa):: an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B

WGE Cooksley et al.

JOURNAL OF VIRAL HEPATITIS (2003)

Article Gastroenterology & Hepatology

Histological outcome during long-term lamivudine therapy

JL Dienstag et al.

GASTROENTEROLOGY (2003)